Seòmar agus comataidhean

The information requested is not held centrally by the Scottish Government or by Public Health Scotland, however confirmed cervical cancer patients being treated on the 31 day or 62 day pathway, with their waiting times, can be found at:

Cancer waiting times - 1 July to 30 September 2021 - Cancer waiting times - Publications - Public Health Scotland

Colposcopy capacity has been impacted by Covid-19, regrettably resulting in longer than usual waiting times in some Health Boards.

In recognition of this, last year we provided over £660,000 additional funding to NHS Ayrshire & Arran, NHS Greater Glasgow & Clyde, NHS Highland, NHS Lothian and NHS Tayside to support capacity in colposcopy provision. The funding was used to enhance capacity through additional workforce and extra clinics, including at weekends.

We will continue to work closely with Boards who are facing challenges in order to remobilise services as soon as possible.

Information on the number of diagnostic procedures performed in NHS Scotland is available on the Public Health Scotland website and can be found in the Acute Hospitals and Finance Cost Books . However, the activity data published for radiology in the Finance Cost Books is reported with elective and emergency totals combined, which does not allow us to report on elective diagnostics activity disaggregated. Further, the Acute Hospitals publication only publishes activity data on particular endoscopy tests, therefore it cannot give us a complete picture for endoscopy activity. Data on the ongoing waits of diagnostic procedures can be found in the PHS Diagnostics publication .

We have provided £29 million to support an increase in diagnostic procedures by 78,000 during the current year and expect diagnostic capacity to increase by at least 90,000 procedures per year by the end of the NHS Recovery Plan in 2025/26. This equates to 29,000 additional CT scans, 24,000 MRI scans and 25,000 additional endoscopy procedures by the end of the Plan.

When minimum unit pricing for alcohol was introduced on 1 May 2018, we said we would review the level two years after its introduction, so from May 2020. With the arrival of COVID-19, this work was paused as responding to the pandemic became the Scottish Government’s top priority.

The review work is now back underway. The impacts of the pandemic, and to some extent Brexit, however, make both the review and the evaluation more challenging. The pandemic, in particular, caused people’s drinking habits to change and, early signs are that this is having an impact on alcohol harms.

As regards the timescale for reviewing the level of MUP, it is currently too early in the process to set out when this might happen.

We remain convinced that MUP is one of the main drivers in reducing alcohol harm.

The draft Framework was shaped throughout 2020 and 2021 by a range of stakeholders, including the patient representatives of the National Advisory Committee on Chronic Pain (NACCP). All members of the NACCP were informed of the proposed approach in advance, were provided with an advanced copy of the Framework and were encouraged to share their feedback on its content via the public consultation. The consultation closes on the 28 February and I would encourage everyone with an interest in improving care and support for people with chronic pain to participate and share their views.

No private marketing company has been used for work relating to the Draft Framework for Pain Management Service Delivery .

The contract was awarded under the Crown Commercial Service Management Consultancy Framework Three following a fair and open procurement exercise in line with Scottish Government guidance.

There is no conflict of interest between existing Scottish Government Civil Servants and the specialist consultancy services procured from KPMG in a fair and open procurement exercise. The Scottish Government has a clear contract award and management processes in place to prevent conflicts of interest and to support the delivery of fit for purpose outcomes. This includes clear requirements for separation of duties between finance and procurement decisions.

Since the emergence of the Omicron, the Scottish Government has undertaken a series of regular meetings with NHS Chief Executives to discuss contingency and resilience planning. These include meetings that were Chaired by the NHS Scotland Chief Executive and Chief Operating Officer as well as regular meetings between health and social care officials and NHS Scotland Chief Executives. The System Response Group meetings also include representations from wider stakeholder interests and Local Government.

I have held regular update meetings to discuss System Pressures to which all Boards are invited. I have also held meetings with COSLA and officials every Monday to receive updates on the Winter Package.

Finally, I held a number of meetings with specific Local Authorities, Health Boards and HSCPs on a one to one basis where the need arose.

These meeting dates are detailed in the following table:

Following the procurement exercise the award decision was communicated to all bidders on 7 December 2021, with the contract being signed on 13 December 2021. It was subsequently published on the Public Contracts Scotland website on 10 January 2022.